Development of anti-TNF therapy for rheumatoid arthritis.
The aetiology of systemic, autoimmune, chronic inflammatory diseases--such as rheumatoid arthritis--is not known, and their pathogenesis is complex and multifactorial. However, progress in the characterization of intercellular mediators--proteins that are now known as cytokines--has led to the reali...
Egile nagusia: | Feldmann, M |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2002
|
Antzeko izenburuak
-
ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
nork: Feldmann, M, et al.
Argitaratua: (2011) -
TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
nork: Maini, R, et al.
Argitaratua: (1993) -
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
nork: Taylor, P, et al.
Argitaratua: (2009) -
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
nork: Feldmann, M, et al.
Argitaratua: (2001) -
Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
nork: Maini, R, et al.
Argitaratua: (2000)